Efficacy and safety analysis of 3D slicer 3D reconstruction technology assisted neuroendoscopic surgery in the treatment of cerebral hemorrhage

doi:10.19854/j.cnki.1008-2425.2024.02.0004

Abstract

Abstract: Objective To evaluate the efficacy and safety of 3D-Slicer 3D reconstruction technology assisted neuroendoscopic surgery in the treatment of cerebral hemorrhage. Methods The clinical data of 98 patients with cerebral hemorrhage in our hospital from January 2021 to January 2023 were collected.They were divided into control group(n=48, neuroendoscopic surgery) and observation group(n=50, 3D-Slicer 3D reconstruction technology assisted neuroendoscopic surgery).The clinical efficacy and complications of the two groups were recorded and compared, and the perioperative indicators, laboratory indicators and prognosis indicators of the two groups were compared. Results The total effective rate of the observation group after treatment was significantly higher than that of the control group(96.00% vs 83.33%)(P＜0.05).The operation time and postoperative hospital stay in the observation group were significantly shorter than those in the control group, the intraoperative blood loss was less than that in the control group, and the hematoma clearance rate was higher than that in the control group(P＜0.05).After treatment, the levels of CRP、TNF-α、NSE and NHISS、mRS scores of the two groups were lower than those before treatment, and the ADL score was higher, especially in the observation group(P＜0.05).The total incidence of postoperative complications in the observation group was 4.00%, which was significantly lower than 16.67% in the control group(P＜0.05). Conclusion 3D-Slicer 3D reconstruction technology assisted neuroendoscopic surgery in the treatment of cerebral hemorrhage has significant curative effect, which can improve the hematoma clearance rate, reduce surgical trauma, promote the recovery of patients' daily life function and nerve function, and has certain safety.

Key words: Cerebral hemorrhage, 3D slicer 3D reconstruction technology, Neuroendoscopic surgery, Safety, Clinical efficacy

摘要： 目的 3D-Slicer三维重建技术辅助神经内镜手术治疗脑出血的有效性及安全性。方法收集本院2021年1月至2023年1月收治的98例脑出血患者的临床资料。按不同手术方法分为对照组(n=48,神经内镜手术)与观察组(n=50,3D-Slicer三维重建技术辅助神经内镜手术治疗)。记录并对比两组患者临床疗效、并发症,对比两组患者围手术期指标、实验室指标及预后指标。结果观察组治疗后总有效率显著高于对照组(96.00% vs 83.33%)(P＜0.05)。观察组手术时间、术后住院时间明显短于对照组,术中出血量少于对照组,血肿清除率高于对照组(P＜0.05)。治疗后,两组患者CRP、TNF-α、NSE水平及NHISS、mRS评分均较治疗前降低,ADL评分增高,以观察组改善效果更显著(P＜0.05)。观察组术后并发症总发生率为4.00%,明显低于对照组的16.67%(P＜0.05)。结论 3D-Slicer三维重建技术辅助神经内镜手术治疗脑出血疗效显著,可提高血肿清除率,降低手术创伤,促进患者日常生活功能、神经功能恢复,且具有一定安全性。

关键词: 脑出血, 3D-Slicer三维重建技术, 神经内镜手术, 安全性, 临床疗效

CLC Number:

R743.34

Lei Hui, Dong Jufeng, Pan Cunyun, Di Li Xiati. Efficacy and safety analysis of 3D slicer 3D reconstruction technology assisted neuroendoscopic surgery in the treatment of cerebral hemorrhage[J]. Chinese Journal of Stereotactic and Functional Neurosurgery, 2024, 37(2): 83-88.

雷, 辉, 董举峰, 潘存云, 迪力夏提. 3D-Slicer三维重建技术辅助神经内镜手术治疗脑出血的有效性及安全性分析[J]. 立体定向和功能性神经外科杂志, 2024, 37(2): 83-88.

References

[1] 张山,武一平,祁红辉,等.3D-Slicer三维重建技术辅助神经内镜下血肿清除术与显微镜下小骨窗开颅血肿清除术治疗高血压基底核区出血的疗效比较研究[J].实用心脑肺血管病杂志,2021,29(5):113~117.
[2] Asad SD,Lombardi SR,Staff I,et al.Abstract TP352:safety and efficacy of andexanet alfa In patients with life threatening intracerebral hemorrhage:a single center experience[J].Stroke,2020,51(4):106~109.
[3] Sattur MG,Spiotta AM.Commentary:Efficacy and Safety of Minimally Invasive Surgery With Thrombolysis in Intracerebral Haemorrhage Evacuation(MISTIE III):A Randomized,Controlled,Open-Label,Blinded Endpoint Phase 3 Trial[J].Neurosurgery,2020,86(5):444~446.
[4] 杨利辉,贾亚男,闫建敏,等.3D-slicer辅助神经内镜与经侧裂手术治疗高血压脑出血疗效对比[J].立体定向和功能性神经外科杂志,2021,34(3):176~179.
[5] 马潞,李浩,吴波,等.自发性脑出血诊断治疗中国多学科专家共识[J].中华急诊医学杂志,2015,24(12):1319~1323.
[6] Koggel LM,Wahab PJ,Robijn RJ,et al.Efficacy and Safety of 100 Laparoscopy-Assisted Transgastric Endoscopic Retrograde Cholangiopancreatography Procedures in Patients with Roux-en-Y Gastric Bypass[J].Obesity Surgery,2021,31(3):987~993.
[7] 王凤伟,杨金庆,薛勇.3D-Slicer软件辅助神经内镜手术治疗高血压性基底节区出血[J].中国临床神经外科杂志,2020,25(7):470~471.
[8] 叶富跃,杨堃,马春阳,等.3D-Slicer联合智能手机辅助定位下神经内镜血肿清除术对基底节区脑出血患者的应用价值研究[J].中国临床神经科学,2022,30(1):49~55.
[9] 黄毅,黄常坚,黄建荣.3D-Slicer软件联合手机导航辅助神经内镜手术治疗基底节区高血压脑出血患者的临床效果[J].广西医学,2022,44(12):1425~1428.
[10] Mcgovern BH,Sims M,Kraft C,et al.Efficacy and Safety of Investigational Microbiome Drug SER-109 for Treatment of Recurrent Clostridioides difficile Infection[J].Gastroenterology,2021,386(3):220~229.
[11] 刘耀赛,李梦双,韦硕,等.基于3D Slicer软件的蝶鞍区三维重建技术在经蝶内镜垂体瘤切除术中的应用价值[J].现代肿瘤医学,2021,29(4):579~584.
[12] 谢军,刘静静,曾海燕,等.3D辅助下神经内镜结合吡拉西坦对脑出血患者血清因子和神经功能影响的临床研究[J].陕西医学杂志,2021,50(4):464~467.
[13] Kim BJ,Kwon SU,Park JH,et al.Cilostazol Versus Aspirin in Ischemic Stroke Patients With High-Risk Cerebral Hemorrhage:Subgroup Analysis of the PICASSO Trial[J].Stroke,2020,51(3):931~937.
[14] 胡志卿,范学政,李明,等.神经内镜辅助3D-slicer导航在高血压脑出血手术中的应用及预后分析[J].神经损伤与功能重建,2021,16(12):756~758.
[15] 李知阳,王文举,魏航宇,等.3 D-slicer软件联合神经内镜手术治疗高血压基底节区脑出血的临床效果及安全性[J].中国医药,2021,16(9):1334~1338.
[16] 金陆昊,孙晓阳.基于3D slicer重建技术和神经内镜对脑出血患者血肿清除效果及对术后并发症的影响[J].中国临床医生杂志,2022,50(12):1480~1483.
[17] Park KY,Yeon JY,Kim BM,et al.Efficacy and Safety of Flow-Diverter Therapy for Recurrent Aneurysms after Stent-Assisted Coiling[J].American Journal of Neuroradiology,2020,41(4):663~668.
[18] Takeuchi K,Nagata Y,Tanahashi K,et al.Efficacy and safety of the endoscopic “wet-field” technique for removal of supratentorial cavernous malformations[J].Acta Neurochirurgica,2022,164(10):2587~2594.
[19] 柳桂红,张利,张于,等.3D-slicer多模态辅助下神经内镜治疗高血压脑出血及术后综合治疗的效果研究[J].中国煤炭工业医学杂志,2022,25(1):81~85.